Illiterate Person

This very sad that great poet Sir Rahat Indori is not with us anymore 😔😔😔
RIP may god bless your soul......

Amazing book entrepreneur!!!!

Amazon Store

What the hell he is saying?
Is he out of his mind?

We just lost a great personality....

America and Russia nay apna kam kr naa shuru kr diya!!!!

Ab yh kya suna mai aarha ki 2023 tak railway private hojaye gyi!!!
Modi selling our most giving job sector..
😣😔😔😔

Shouldn't he be in jail for false clam on corona vaccine.
🤔🤔🤔🤔😔😔

OAKLAND, Calif. (Reuters) - California regulators sued Cisco Systems Inc on Tuesday, accusing it of discriminating against an Indian-American employee and allowing him to be harassed by two managers because he was from a lower Indian caste than them.

U.S. employment law does not specifically bar caste-based discrimination, but California's Department of Fair Employment and Housing contends in the lawsuit that the Hindu faith's lingering caste system is based on protected classes such as religion.

The lawsuit, filed in federal court in San Jose, does not name the alleged victim. It states he has been a principal engineer at Cisco's San Jose headquarters since October 2015 and that he was born at the bottom of caste hierarchy as a Dalit, once called "untouchables."
Like other large Silicon Valley employers, Cisco's workforce includes thousands of Indian immigrants, most of whom were born Brahmins or other high castes.

Former Cisco engineering managers Sundar Iyer and Ramana Kompella also are defendants in the lawsuit, which accuses them of harassment for internally enforcing the caste hierarchy.

Cisco spokeswoman Robyn Blum said the network gear maker followed its process to investigate employee concerns in this case and would "vigorously defend itself" against the lawsuit.

"Cisco is committed to an inclusive workplace for all," she said. "We were fully in compliance with all laws as well as our own policies."

Iyer and Kompella did not immediately respond to requests for comment. It was not immediately known if the two have retained attorneys.

The civil rights group Equality Labs in a 2018 report cited in the lawsuit found that 67% of Dalits surveyed felt treated unfairly at their U.S. workplaces.
At Cisco, the unnamed employee reported Iyer to human resources in November 2016 for outing him as a Dalit to colleagues. Iyer allegedly retaliated, but Cisco determined caste discrimination was not illegal and issues continued through 2018, the lawsuit states.

Cisco reassigned and isolated the employee, rejected a raise and opportunities that would have led to one and denied two promotions, according to the lawsuit.

Hindus traditionally grouped people into four major castes based on ancestry, and Dalits in India still struggle with access to education and jobs 65 years after India banned caste-based discrimination.

BJP wala corona virus say bhi jyada khaternk hai!!!!!!
Logo k liya😔😔😔😔

Hours after a splashy launch of its claimed ayurvedic treatment for the novel coronavirus, Patanjali Ayurved Ltd. was told by the government to stop advertising or publicising any such claim due to the lack of requisite approval. The legal provisions cited in the ministry statement also indicate that Patanjali cannot sell the product as of now.

The facts and claims made by Patanjali of the efficacy of its virus medicine, branded ‘Coronil’, were not known to the Ministry of AYUSH, according to a statement by the ministry that governs ayurvedic medicines. It asked Patanjali to stop advertising and publicising claims till the issue is examined.

“In order to make this Ministry aware of the facts of the aforesaid news and verify the claims, Patanjali Ayurved Ltd. has been asked to provide at the earliest details of the name and composition of the medicines being claimed for Covid treatment; site(s)/hospital(s), where the research study was conducted for Covid-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicising such claims till the issue is duly examined. Ministry has also requested concerned State Licensing Authority of Uttarakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19.”
Patanjali has now been cautioned by the ministry that advertising such a drug, including an Ayurvedic medicine, is regulated by the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules and directives issued by the central government pursuant to the virus outbreak.

The ministry statement also cites an April notification that lays downs guidelines for development of drugs based on any of the AYUSH systems -- Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy -- recognised under the Drugs and Cosmetics Act, 1940.

As per those guidelines, recognised scientists, researchers and clinicians can undertake research on such drugs provided

the proposals are approved by their scientific advisory bodies and Institutional ethics Committees
clinical trials, if any, are registered with CTRI
sample size should be based on statistical justification
research should be conducted as per AYUSH guidelines
compliance with relevant ICMR guideline among other requirements
The ministry’s April notification also makes clear that it must be appraised by the institution or organisation conducting such research about the developments timeline and outcome.
Since, the ministry said it had no information on the Patanjali medicine, does that suggest that the company does not even have clearance to sell the product?

Murali Neelakantan, a lawyer who has worked in the pharmaceutical industry, said based on the statement issued by AYUSH ministry it is fair to deduce that the product has not been licensed under Chapter IVA of the Drugs & Cosmetics Act and Rule 158(B) of the Drugs & Cosmetics Rules.

As a consequence, the manufacture or sale of this product is punishable under section 33I of the Drugs Act,” Neelakantan said in an email comment.

Even if each of the ingredients in the product is licensed for manufacture and sale, advertisement of the claim that it cures Covid is a clear violation of section 3 (d) of the Magic Remedies Act, 1954, he added. “I am surprised that the press is carrying the story and effectively “advertising” the product, a violation of section 4 of the same legislation.”

Patanjali’s Acharya tweeted late evening that his company has met all parameters of randomised placebo controlled clinical trials and has provided information to the ministry.

Some Ray of Hope☀️☀️☀️😷😷😷
Dexamethasone emerges as first Covid-19 life-saving drug: All you need to know
Coronavirus Drug Dexamethasone: Dexamethasone is a generic steroid widely used in other diseases to reduce inflammation. The drug helps stop some of the damage that can happen when the body's immune system goes into overdrive as it tries to fight off coronavirus.
Coronavirus Drug Dexamethasone: In a major breakthrough in Covid-19 treatment, scientists in UK have claimed that the generic steroid drug dexamethasone reduced deaths by up to one third in severely ill hospitalised patients. The results are a part of UK-based RECOVERY trial, one of the world’s largest randomised trial of drugs to treat COVID-19 patients.

This is the same study that earlier this month showed the malaria drug hydroxychloroquine was not working against the coronavirus.